Dreamz College of pharmacy, Khilra- Meramesit, Sundernagar-175036, Mandi (Himachal Pradesh), India.
Expert Opin Drug Deliv. 2012 Feb;9(2):141-9. doi: 10.1517/17425247.2012.633507. Epub 2012 Jan 11.
The aim of this study is to develop, characterize and evaluate (in vitro and in vivo) a novel colon-targeted bioadhesive microsphere (BAM) containing metronidazole (MTZ).
BAMs are prepared using Assam Bora rice starch as a natural bioadhesive polymer by a double emulsion solvent evaporation method.
The prepared microspheres showed a uniform spherical shape, with excellent retention time. The in vitro drug release study of the optimized formulations, in different physiological environments, confirmed the insignificant release of metronidazole in the physiological conditions of the stomach (10 - 12.5%) and small intestine (< 25%). Further, fast and major drug release in cecal content (> 90) indicated that the release of the drug was unaffected by the hostile environment of the gastrointestinal tract (GIT). In vitro bacterial inhibition studies illustrated that MTZ loaded BAMs, inhibiting metronidazole-sensitive Bacteroides fragilis and selected BAMs (F1 - F7), have an equivalent or higher zone of inhibition than the marketed formulation. An in vivo organ distribution study of MTZ revealed that Assam Bora rice starch-based microspheres were relatively intact in the upper part of GIT, and the drug was released only after reaching the colon, owing to the microbial degradation of Assam Bora rice starch by microflora residing in the colon.
MTZ release patterns exhibited slow and extended release over longer periods of time, which shows the potential of Assam Bora rice starch microspheres as a drug carrier for an effective colon-targeted delivery system.
本研究旨在开发、表征和评估(体外和体内)一种新型的含有甲硝唑的结肠靶向生物黏附微球(BAM)。
采用 Assam Bora 大米淀粉作为天然生物黏附聚合物,通过双乳液溶剂蒸发法制备 BAMs。
所制备的微球呈均匀的球形,具有优异的保留时间。在不同生理环境下对优化配方的体外药物释放研究表明,甲硝唑在胃的生理条件下(10-12.5%)和小肠中(<25%)释放不明显。此外,在盲肠内容物中(>90%)快速且主要的药物释放表明药物的释放不受胃肠道(GIT)恶劣环境的影响。体外细菌抑制研究表明,载有甲硝唑的 BAMs 抑制甲硝唑敏感的脆弱拟杆菌和选定的 BAMs(F1-F7)的抑制环与市售制剂相当或更高。甲硝唑的体内器官分布研究表明,基于 Assam Bora 大米淀粉的微球在 GIT 的上部相对完整,并且只有到达结肠后才释放药物,这是由于结肠中微生物对 Assam Bora 大米淀粉的降解。
甲硝唑的释放模式显示出缓慢和延长的释放,在更长的时间内释放,这表明 Assam Bora 大米淀粉微球作为一种有效的结肠靶向给药系统的药物载体具有潜力。